<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition

minute read

by Pharmacy Focus | November 18, 2025
placeholder

Joe Saseen, PharmD, speaks with Pharmacy Focus' Tell Tale Heart about several key trials presented at the American Heart Association 2025 Scientific Sessions.

Topics: Press Coverage

Comments